Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.

Ruxolitinib phosphate is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Visionaries of 1925 made their best guesses about the 21st century. Predictions included world peace, food shortages and ...

Deputy Agrarian Development Commissioner Kelum Dissanayake told Daily  News that Rs.1244 million has been paid to the farmers ...

All eight divisional commissioners have been asked to stand guard against unscrupulous dealers jacking up fertilizer prices ...

When the peptide and phosphate bind to manganese, they create a ternary, or triple, complex that is highly effective in protecting against radiation. Together, the metabolites in MDP create a ...

Milk is our largest agri-commodity, the value of which exceeds the value of rice, wheat, pulses, and sugarcane put together.

Stay updated on the latest news in the lithium market, including price trends, government policies, and mining developments ...

Lithium-ion batteries were good enough to start the EV revolution. Here are the upcoming battery technologies that are good ...

Cobalt demand will triple by 2050 as the energy transition ... Non-cobalt-containing batteries (mostly lithium-phosphate-iron batteries, or LFPs) are lower-cost at present. But even in China ...

According to the International Energy Agency, clean energy technology minerals are set to triple by 2030 and quadruple ... with alternatives like lithium iron phosphate batteries—used in 40 ...